From the Mouse Cage to Human Therapy: A Personal Perspective of the Emergence of T-bodies/Chimeric Antigen Receptor T Cells
At the end of november 2013, Science magazine chose the advances made in Cancer Immunotherapy as the breakthrough of the year (Couzin-Frankel, 2013). The dramatic clinical outcome of patients treated with chimeric antigen receptor (CAR) T cells has been described as one of the major turning points of cancer therapy. In the framework of the annual issue of the journal of Human Gene Therapy that is dedicated to personal perspectives by scientists who have pioneered the field, I am honored to represent the members of my lab who have worked alongside me in establishing the CAR T cell approach (which we nicknamed “T-bodies”) and taken it from its initial proof of concept, through experimental animal studies, until its recent successful testing by our fellow clinicians in cancer patients.
Checking your browser - reCAPTCHA Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.
Explore this link on the map →related reading
- Medicine's Endgamenotboring.co
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- 癌症治療的海豹特種部隊 淺談CAR-T細胞治療法::台灣癌症基金會canceraway.org.tw
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- The blood cancer that became solvableworksinprogress.news
- Teaching an old dog new tricks: next-generation CAR T cells | British Journal of Cancernature.com
- Immunotherapy for Cancer - NCIcancer.gov
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- What is tumor-infiltrating lymphocyte (TIL) therapy? | UT MD Andersonmdanderson.org
- Google’s Gemma AI model helps discover new potential cancer therapy pathwayblog.google
- Targeting telomerase for cancer therapy | Oncogenenature.com
- The Frontier in 2025renaissancephilanthropy.org